With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden.
For more information, visit www.lantheus.com.
Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world.
For more information on Astellas, please visit: https://www.astellas.com/us You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/
Blue Earth Diagnostics, one of the Bracco family of companies, is a recognized global industry leader in the development and commercialization of innovative, precision imaging radiopharmaceuticals that help to diagnose, stage and monitor cancer for patients in areas of unmet medical need. Formed in 2014, Blue Earth Diagnostics is led by proven experts in nuclear medicine, with a demonstrated track record in the rapid development and commercialization of positron emission tomography (PET) radiopharmaceuticals with a consistent commitment to providing service to its customers. Blue Earth Diagnostics’ products include a world-class franchise of PET diagnostic imaging agents for prostate cancer and an expanding pipeline portfolio that spans a variety of disease states, including neuro-oncology and multiple solid tumors.
For more information, please visit: blueearthdiagnostics.com and prostatecancer-blueearthdx.com
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at https://www.jnj.com/ or at www.janssen.com/johnson-